Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | ISO | Syngr2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SYNGR2 mRNA | CTD | PMID:36331819 | (S)-nicotine | multiple interactions | ISO | Syngr2 (Mus musculus) | 6480464 | [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... | CTD | PMID:20230807 | 1,2-dimethylhydrazine | increases expression | ISO | Syngr2 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of SYNGR2 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | multiple interactions | ISO | Syngr2 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of SYNGR2 mRNA | CTD | PMID:22206623 | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | decreases expression | ISO | Syngr2 (Mus musculus) | 6480464 | 1-Methyl-4-phenyl-1 more ... | CTD | PMID:20230807 | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | multiple interactions | ISO | Syngr2 (Mus musculus) | 6480464 | [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... | CTD | PMID:20230807 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of SYNGR2 mRNA | CTD | PMID:30165855 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Syngr2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SYNGR2 mRNA | CTD | PMID:17949056 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Syngr2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SYNGR2 mRNA | CTD | PMID:21570461 | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:26705709 | 2-hydroxypropanoic acid | increases expression | EXP | | 6480464 | Lactic Acid results in increased expression of SYNGR2 mRNA | CTD | PMID:30851411 | 3,3',4,4'-tetrachlorobiphenyl | multiple interactions | ISO | Syngr2 (Mus musculus) | 6480464 | 3 more ... | CTD | PMID:19467301 | 4,4'-sulfonyldiphenol | increases expression | ISO | Syngr2 (Mus musculus) | 6480464 | bisphenol S results in increased expression of SYNGR2 mRNA | CTD | PMID:30951980 | 6-propyl-2-thiouracil | decreases expression | ISO | Syngr2 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of SYNGR2 mRNA | CTD | PMID:24780913 | aconitine | decreases expression | ISO | Syngr2 (Rattus norvegicus) | 6480464 | Aconitine results in decreased expression of SYNGR2 protein | CTD | PMID:33236894 | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of SYNGR2 mRNA | CTD | PMID:23724009 | Allylamine | increases expression | ISO | Syngr2 (Rattus norvegicus) | 6480464 | Allylamine results in increased expression of SYNGR2 mRNA | CTD | PMID:15910882 | antirheumatic drug | decreases expression | EXP | | 6480464 | Antirheumatic Agents results in decreased expression of SYNGR2 mRNA | CTD | PMID:24449571 | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of SYNGR2 mRNA | CTD | PMID:33212167 | arsenite(3-) | multiple interactions | EXP | | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to SYNGR2 protein] | CTD | PMID:32406909 | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of SYNGR2 3' UTR | CTD | PMID:27901495 | bis(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in increased expression of SYNGR2 mRNA | CTD | PMID:31163220 | bisphenol A | increases expression | ISO | Syngr2 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of SYNGR2 mRNA | CTD | PMID:25181051 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of SYNGR2 gene | CTD | PMID:31601247 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of SYNGR2 gene | CTD | PMID:31601247 | bisphenol A | increases expression | ISO | Syngr2 (Mus musculus) | 6480464 | bisphenol A results in increased expression of SYNGR2 mRNA | CTD | PMID:33221593 | bisphenol A | decreases expression | ISO | Syngr2 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of SYNGR2 mRNA | CTD | PMID:30816183 | bortezomib | decreases expression | EXP | | 6480464 | Bortezomib results in decreased expression of SYNGR2 mRNA | CTD | PMID:20977926 | chlorpyrifos | increases expression | ISO | Syngr2 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of SYNGR2 mRNA | CTD | PMID:37019170 | cisplatin | increases expression | ISO | Syngr2 (Rattus norvegicus) | 6480464 | Cisplatin results in increased expression of SYNGR2 protein | CTD | PMID:15033597 | clofibrate | decreases expression | ISO | Syngr2 (Mus musculus) | 6480464 | Clofibrate results in decreased expression of SYNGR2 mRNA | CTD | PMID:17585979 | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of SYNGR2 mRNA | CTD | PMID:19376846 | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of SYNGR2 mRNA | CTD | PMID:19549813 | Cuprizon | decreases expression | ISO | Syngr2 (Rattus norvegicus) | 6480464 | Cuprizone results in decreased expression of SYNGR2 mRNA | CTD | PMID:26577399 | dibutyl phthalate | decreases expression | ISO | Syngr2 (Rattus norvegicus) | 6480464 | Dibutyl Phthalate results in decreased expression of SYNGR2 mRNA | CTD | PMID:21266533 | dioxygen | multiple interactions | ISO | Syngr2 (Mus musculus) | 6480464 | [sulforaphane affects the susceptibility to Oxygen] which affects the expression of SYNGR2 mRNA | CTD | PMID:30529165 | doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of SYNGR2 mRNA | CTD | PMID:29803840 | entinostat | increases expression | EXP | | 6480464 | entinostat results in increased expression of SYNGR2 mRNA | CTD | PMID:27188386 | epoxiconazole | decreases expression | ISO | Syngr2 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of SYNGR2 mRNA | CTD | PMID:35436446 | fenthion | increases expression | ISO | Syngr2 (Mus musculus) | 6480464 | Fenthion results in increased expression of SYNGR2 mRNA | CTD | PMID:34813904 | folic acid | multiple interactions | ISO | Syngr2 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of SYNGR2 mRNA | CTD | PMID:22206623 | FR900359 | increases phosphorylation | EXP | | 6480464 | FR900359 results in increased phosphorylation of SYNGR2 protein | CTD | PMID:37730182 | fulvestrant | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of SYNGR2 gene | CTD | PMID:31601247 | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of SYNGR2 protein | CTD | PMID:32959892 | N-methyl-4-phenylpyridinium | increases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of SYNGR2 mRNA | CTD | PMID:24810058 | nefazodone | increases expression | ISO | Syngr2 (Rattus norvegicus) | 6480464 | nefazodone results in increased expression of SYNGR2 mRNA | CTD | PMID:24136188 | nicotine | multiple interactions | ISO | Syngr2 (Mus musculus) | 6480464 | [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... | CTD | PMID:20230807 | paracetamol | increases expression | ISO | Syngr2 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of SYNGR2 mRNA | CTD | PMID:33387578 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Syngr2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SYNGR2 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of SYNGR2 mRNA | CTD | PMID:36331819 | potassium chromate | increases expression | EXP | | 6480464 | potassium chromate(VI) results in increased expression of SYNGR2 mRNA | CTD | PMID:22714537 | rac-lactic acid | increases expression | EXP | | 6480464 | Lactic Acid results in increased expression of SYNGR2 mRNA | CTD | PMID:30851411 | Soman | increases expression | ISO | Syngr2 (Rattus norvegicus) | 6480464 | Soman results in increased expression of SYNGR2 mRNA | CTD | PMID:19281266 | sulforaphane | multiple interactions | ISO | Syngr2 (Mus musculus) | 6480464 | [sulforaphane affects the susceptibility to Oxygen] which affects the expression of SYNGR2 mRNA | CTD | PMID:30529165 | titanium dioxide | increases expression | ISO | Syngr2 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of SYNGR2 mRNA | CTD | PMID:23409001 | triclosan | decreases expression | EXP | | 6480464 | Triclosan results in decreased expression of SYNGR2 mRNA | CTD | PMID:30510588 | triptonide | decreases expression | ISO | Syngr2 (Mus musculus) | 6480464 | triptonide results in decreased expression of SYNGR2 mRNA | CTD | PMID:33045310 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of SYNGR2 mRNA | CTD | PMID:25979313 | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of SYNGR2 gene | CTD | PMID:29154799 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of SYNGR2 mRNA | CTD | PMID:23179753 more ... | vancomycin | increases expression | ISO | Syngr2 (Mus musculus) | 6480464 | Vancomycin results in increased expression of SYNGR2 mRNA | CTD | PMID:18930951 | vinclozolin | affects expression | ISO | Syngr2 (Rattus norvegicus) | 6480464 | vinclozolin affects the expression of SYNGR2 mRNA | CTD | PMID:19015723 | |